HK1043322B - 四氢苯并[cd]吲-6-甲酰胺类化合物在制备用於预防呕吐的药物中的用途 - Google Patents

四氢苯并[cd]吲-6-甲酰胺类化合物在制备用於预防呕吐的药物中的用途 Download PDF

Info

Publication number
HK1043322B
HK1043322B HK02105194.1A HK02105194A HK1043322B HK 1043322 B HK1043322 B HK 1043322B HK 02105194 A HK02105194 A HK 02105194A HK 1043322 B HK1043322 B HK 1043322B
Authority
HK
Hong Kong
Prior art keywords
indole
tetrahydrobenzo
carboxamide
compounds
emesis
Prior art date
Application number
HK02105194.1A
Other languages
English (en)
Chinese (zh)
Other versions
HK1043322A1 (en
Inventor
Mortensen Foreman Mark
David Leander J.
Original Assignee
伊莱利利公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 伊莱利利公司 filed Critical 伊莱利利公司
Publication of HK1043322A1 publication Critical patent/HK1043322A1/xx
Publication of HK1043322B publication Critical patent/HK1043322B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HK02105194.1A 1993-06-10 2002-07-12 四氢苯并[cd]吲-6-甲酰胺类化合物在制备用於预防呕吐的药物中的用途 HK1043322B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7519893A 1993-06-10 1993-06-10
US075198 1993-06-10

Publications (2)

Publication Number Publication Date
HK1043322A1 HK1043322A1 (en) 2002-09-13
HK1043322B true HK1043322B (zh) 2005-06-03

Family

ID=22124191

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105194.1A HK1043322B (zh) 1993-06-10 2002-07-12 四氢苯并[cd]吲-6-甲酰胺类化合物在制备用於预防呕吐的药物中的用途

Country Status (17)

Country Link
US (1) US5703112A (enExample)
EP (2) EP0633023A3 (enExample)
JP (1) JPH0748254A (enExample)
KR (2) KR100367792B1 (enExample)
CN (2) CN1072932C (enExample)
AU (1) AU677317B2 (enExample)
CA (1) CA2125088A1 (enExample)
CZ (2) CZ285762B6 (enExample)
HK (1) HK1043322B (enExample)
HU (1) HUT71464A (enExample)
IL (1) IL109872A (enExample)
NO (4) NO321500B1 (enExample)
NZ (2) NZ260667A (enExample)
RU (1) RU2154476C2 (enExample)
TW (1) TW258660B (enExample)
UA (2) UA29415C2 (enExample)
ZA (1) ZA943862B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002543128A (ja) 1999-04-30 2002-12-17 リリー アイコス リミテッド ライアビリティ カンパニー 雌性覚醒障害の処置
RU2154490C1 (ru) * 1999-07-15 2000-08-20 Кибрик Николай Давидович Способ лечения сексуальных расстройств диэнцефального генеза у мужчин
GB0106446D0 (en) * 2001-03-15 2001-05-02 Vernalis Res Ltd Chemical compounds
RU2200556C1 (ru) * 2001-12-05 2003-03-20 Северцев Владимир Алексеевич Лекарственная форма налтрексона
DK1890684T3 (da) 2005-06-08 2013-10-14 Sk Biopharmaceuticals Co Ltd Behandling af søvn/vågenhedsforstyrrelser
WO2007001841A1 (en) * 2005-06-22 2007-01-04 Sk Holdings Co., Ltd. Treatment of sexual dysfunction
US8741950B2 (en) 2009-06-22 2014-06-03 Sk Biopharmaceuticals Co., Ltd. Methods for treating or preventing fatigue
JP5836280B2 (ja) 2009-11-06 2015-12-24 エスケー バイオファーマスティカルズ カンパニー リミテッド 注意欠陥／多動性障害（ａｄｈｄ）の治療方法
JP5901528B2 (ja) 2009-11-06 2016-04-13 エスケー バイオファーマスティカルズ カンパニー リミテッド 線維筋痛症候群の治療方法
US9610274B2 (en) 2010-06-30 2017-04-04 Sk Biopharmaceuticals Co., Ltd. Methods for treating bipolar disorder
AU2014248849B2 (en) 2013-03-13 2018-08-30 Jazz Pharmaceuticals Ireland Limited Treatment of cataplexy
CN105873576B (zh) 2013-07-18 2019-07-19 爵士制药国际Iii有限公司 治疗肥胖
US10195151B2 (en) 2016-09-06 2019-02-05 Jazz Pharmaceuticals International Iii Limited Formulations of (R)-2-amino-3-phenylpropyl carbamate
CA3065522A1 (en) 2017-06-02 2018-12-06 Jazz Pharmaceuticals Ireland Limited Methods and compositions for treating excessive sleepiness
US10940133B1 (en) 2020-03-19 2021-03-09 Jazz Pharmaceuticals Ireland Limited Methods of providing solriamfetol therapy to subjects with impaired renal function

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110339A (en) * 1977-11-25 1978-08-29 Eli Lilly And Company 4-(Di-n-propyl)amino-1,3,4,5-tetrahydrobenz[cd]indole
US4521421A (en) * 1983-09-26 1985-06-04 Eli Lilly And Company Treatment of sexual dysfunction
US4576959A (en) * 1984-02-06 1986-03-18 Eli Lilly And Company 6-Substituted-4-dialkylaminotetrahydrobenz[c,d]indoles
CA1266482A1 (en) * 1984-05-24 1990-03-06 Carl Kaiser 6-oxygenated-1,3,4,5-tetrahydrobenz(cd)indol-4-amines
US4745126A (en) * 1987-03-12 1988-05-17 Eli Lilly And Company Method of treating anxiety with tetrahydrobenz[c,d]indole-6-carboxamides
US4943428A (en) * 1987-07-10 1990-07-24 Wright State University Stimulation of serotonin-1A receptors in mammals to alleviate motion sickness and emesis induced by chemical agents
DE3809155A1 (de) * 1988-03-18 1989-09-28 Bayer Ag 1,3,4,5-tetrahydrobenz-(c,d)-indole
US5204340A (en) * 1989-04-11 1993-04-20 Eli Lilly And Company Tetrahydrobenz(c,d)indole serotonin agonists
KR0151699B1 (ko) * 1989-07-13 1998-10-15 로버트 에이. 아미테이지 (1,2n) 및 (3,2n)-카보사이클릭-2-아미노테트랄린 유도체
IL97308A (en) * 1990-02-26 1996-10-31 Lilly Co Eli 6-Substituted-hexahydrobenz (cd) indoles process for their preparation and pharmaceutical compositions containing them
US5302612A (en) * 1990-02-26 1994-04-12 Eli Lilly And Company 6-substituted-hexahydrobenz[cd]indoles
WO1991013872A1 (en) * 1990-03-15 1991-09-19 The Upjohn Company Therapeutically useful heterocyclic indole compounds
US5258379A (en) * 1990-05-04 1993-11-02 Eli Lilly And Company Method of inhibiting gastric acid secretion with n-arylpiperazines
US5096908A (en) * 1990-05-04 1992-03-17 Eli Lilly And Company Method of inhibiting gastric acid secretion
US5229409A (en) * 1990-08-15 1993-07-20 Eli Lilly And Company 6-substituted-tetrahydrobenz[cd]indoles
US5244912A (en) * 1991-03-28 1993-09-14 Eli Lilly And Company 6-heterocyclic-4-amino-1,3,4,5-tetrahydrobenz(cd)indoles and pharmaceutical use thereof

Also Published As

Publication number Publication date
CZ285829B6 (cs) 1999-11-17
NO942143L (no) 1994-12-12
IL109872A0 (en) 1994-10-07
NO308693B1 (no) 2000-10-16
NO991551L (no) 1994-12-12
NO20015806D0 (no) 2001-11-28
UA29415C2 (uk) 2000-11-15
EP1166783A2 (en) 2002-01-02
CN1072932C (zh) 2001-10-17
NO321500B1 (no) 2006-05-15
NZ260667A (en) 1997-05-26
HUT71464A (en) 1995-11-28
NO991551D0 (no) 1999-03-30
ZA943862B (en) 1995-12-04
HU9401730D0 (en) 1994-09-28
EP0633023A3 (en) 1995-03-29
HK1043322A1 (en) 2002-09-13
EP0633023A2 (en) 1995-01-11
CN1100634A (zh) 1995-03-29
CZ135494A3 (en) 1994-12-15
KR950000146A (ko) 1995-01-03
KR100367792B1 (ko) 2003-02-19
KR100367791B1 (ko) 2003-02-14
NO20015806L (no) 1994-12-12
IL109872A (en) 2000-12-06
NZ314570A (en) 2000-11-24
EP1166783A3 (en) 2002-01-09
CA2125088A1 (en) 1994-12-11
CN1342457A (zh) 2002-04-03
RU94020717A (ru) 1996-08-27
RU2154476C2 (ru) 2000-08-20
CZ285762B6 (cs) 1999-11-17
JPH0748254A (ja) 1995-02-21
NO993461L (no) 1994-12-12
NO993461D0 (no) 1999-07-14
AU677317B2 (en) 1997-04-17
UA37311C2 (uk) 2001-05-15
TW258660B (enExample) 1995-10-01
US5703112A (en) 1997-12-30
NO942143D0 (no) 1994-06-09
AU6460794A (en) 1994-12-15
CN1170536C (zh) 2004-10-13

Similar Documents

Publication Publication Date Title
HK1043322B (zh) 四氢苯并[cd]吲-6-甲酰胺类化合物在制备用於预防呕吐的药物中的用途
CN1146421C (zh) 治疗疼痛的组合物以及药物在制备所述组合物中的应用
CN1311681A (zh) 顽固性抑郁治疗的联合疗法
CN1606442A (zh) 多动腿综合征的新疗法
CN1520290A (zh) 含铜胺氧化酶的碳环肼基抑制剂
CN1379761A (zh) 稠合二氢吲哚衍生物及其作为5ht特别是5ht2c受体配体的用途
CN1345238A (zh) 用于治疗神经病或神经精神疾病的方法
CN1723021A (zh) 稳定的口服固体药物组合物
CN1106196C (zh) 奥氮平在制备用于治疗偏头痛的药物中的应用
CN1219878A (zh) 治疗疼痛的方法
CN1216598C (zh) 药物用途
WO2002074288A2 (en) Treatment and prevention of sexual dysfunction resulting from ssri-therapy by using a tetrahydrobenz cd indole-6-carboxamide
CN1213966A (zh) 治疗两极紊乱的方法
CN1319532C (zh) N－(吲哚羰基)哌嗪衍生物的用途
CN1124847C (zh) 治疗过度攻击行为的方法
CN1192029C (zh) 学习或记忆改善剂
CN1867333A (zh) 含单胺神经递质再摄取抑制剂和乙酰胆碱酯酶抑制剂的药物组合物
CN1191484A (zh) 治疗良性前列腺增生的褪黑激素激动剂
HK1013796A (en) Preventing emesis and treating sexual dysfunction using tetrahydrobenz cd indole-6-carboxamides
CN1646109A (zh) 应用去甲司来吉兰预防和治疗周围神经病的方法
CN1131035C (zh) 治疗识别机能障碍的方法
CA2508477A1 (en) Method of preventing emesis and treating sexual dysfunction using tetrahydrobenz ¬cd| indole-6-carboxamides
HK1073243B (en) Use of n-(indolecarbonyl-) piperazine derivatives
HK1064603A (en) Pharmaceutical composition for treatment of pain
CN1212627A (zh) 失眠症的治疗方法

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080609